Unannounced · 272 daysFiled 18 December 2025
Delfi Diagnostics, Inc. raised $34.3M
Delfi Diagnostics, Inc., a biotech company based in Palo Alto, CA, raised $34.3M in a new debt round, according to a filing dated 18 December 2025.
No public announcement found as of 15 September 2026, 272 days after the filing.
- Filed
- 18 December 2025
- Round
- Debt round
- Amount sold
- $34.3M
- Offering size
- $60M
- Investors so far
- 50
- Based in
- Palo Alto, CA
- Industry
- Biotech
- Website
- delfidiagnostics.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 83% of the 1,404 tracked raises with an amount filed in 2025, and than 71% of the 112 in biotech.
Delfi Diagnostics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 18 Dec 2025 | New filing | $34.3M | This raise |
| 25 Jul 2022 | New filing | $225M | Another raise |
More with Samsara BioCapital on the board
- Abcuro, Inc.$39.4M
- Claris Biotherapeutics, Inc.$55.7M
- OrsoBio, Inc.$40M
- Alumis Inc.$129M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.